Search for Andrew Witty and
    1. July 27, 2016

      GSK to invest £275m in UK as sales grow for new drugs

      GlaxoSmithKline, the largest UK drug company, is to invest £275m to expand production capacity at three British sites...

    2. Fast FT

      July 27, 2016

      GSK beats expectations in second quarter

      Shares in GlaxoSmithKline jumped as much as 2.4 per cent at lunchtime after it reported Q2 results well ahead of...

    1. FT Alphaville

      July 27, 2016

      FT Opening Quote: GSK signals post-Brexit confidence

      GSK announces UK investment, Taylor Wimpey shrugs off Brexit concerns and Arm Holdings revenues are up. FT Opening...

    2. Fast FT

      July 27, 2016

      GSK invests in UK sites in vote of confidence in Brexit Britain

      GlaxoSmithKline, the largest UK drug company, is to invest an extra £275m at three British manufacturing sites, in a...

    3. Fast FT

      June 14, 2016

      GSK's head of vaccines to depart next year

      The head of vaccines at GlaxoSmithKline, Moncef Slaoui, has told the UK drugmaker that he intends to step down in June...

    4. May 3, 2016

      Witty looks to cement his legacy as GSK’s performance improves

      Sir Andrew Witty’s final 11 months in charge of GlaxoSmithKline will not be the victory lap he might have hoped for...

    5. April 27, 2016

      GSK chief says pressure on US drug prices to rise

      Pressure on drug prices in the US will continue to grow regardless of who wins November’s presidential election, the...

    6. April 27, 2016

      Sir Andrew Witty fuels GSK turnround hopes with results boost

      Sir Andrew Witty began his final year in charge of GlaxoSmithKline with a stronger than expected rise in first-quarter...

    7. Fast FT

      April 27, 2016

      GlaxoSmithKline Q1 growth aided by HIV drugs

      Sir Andrew Witty began his final year in charge of GlaxoSmithKline with a stronger-than-expected rise in first quarter...

    8. April 3, 2016

      GSK returns to battle against cancer

      When GlaxoSmithKline agreed to sell its oncology drugs to Novartis for $16bn in 2014, it looked like the UK...

    9. March 31, 2016

      GSK to relax intellectual property and help developing world

      GlaxoSmithKline has promised not to seek patent protection on medicines in low-income countries as part of measures by...

    10. Fast FT

      March 31, 2016

      GSK to loosen IP protections in poorer countries

      GlaxoSmithKline has promised not to seek patent protection on medicines in low-income countries as part of a range of...

    11. March 17, 2016

      Lessons in succession from GSK and Rio

      If you’ve ever envied folks absorbed in puzzle magazines as you sit shuffling work papers on the train, here’s your...

    12. March 17, 2016

      Miners keep FTSE in positive territory

      A strong performance by miners helped the FTSE 100 close in positive territory on Thursday, offsetting falls among...

    13. March 17, 2016

      Sir Andrew Witty’s tenure at GSK divides opinion

      Two views exist of Sir Andrew Witty. He could be seen as the visionary leader who restructured GlaxoSmithKline for...

    14. March 17, 2016

      GSK: wheel of fortune

      He played a bad hand well is an honourable epitaph for a private life. It will not do for the tenure of a public...

    15. Fast FT

      March 17, 2016

      Opening Quote: GSK/Rio Tinto bosses retiring; Budget sweeteners

      The bosses of GlaxoSmithKline and Rio Tinto are retiring, Ted Baker profits are climbing, there were some artificial...

    16. March 17, 2016

      Sir Andew Witty defends GSK strategy as plans to retire revealed

      Sir Andrew Witty has denied that his departure from GlaxoSmithKline will trigger a break-up of Britain’s biggest...

    17. Fast FT

      March 17, 2016

      Sir Andrew Witty to leave GlaxoSmithKline in 2017

      Sir Andrew Witty, the chief executive of GlaxoSmithKline, will step down from the UK drugmaker next year, the company...

    18. February 28, 2016

      GSK to start search for Andrew Witty’s successor

      GlaxoSmithKline is gearing up to begin a formal search for its next chief executive as Sir Andrew Witty’s eight-year...

    19. February 3, 2016

      GSK’s Witty avoids the City’s would-be surgeons

      Sir Andrew Witty, chief executive of GlaxoSmithKline, is having his yearly City health check up. Corporate doctor: What...

    20. February 3, 2016

      GlaxoSmithKline: stabilising

      A chart of GSK’s share price against the Stoxx Europe 600 Healthcare index during the past year shows an unfamiliar...

    21. February 3, 2016

      GlaxoSmithKline rules out break-up as new drugs boost sales

      GlaxoSmithKline has all but ruled out a sale of its consumer healthcare business in the next three years, disappointing...

    22. Fast FT

      February 3, 2016

      GSK profits suffers steep fall in 2015

      GlaxoSmithKline suffered a steep fall in profits in 2015 and there was no let up in the decline during the fourth...

    23. January 25, 2016

      Brexit would be a ‘mistake’, say global pharma leaders

      A British exit from the EU would isolate the country’s scientists and reduce its influence in medicine, global...

    24. January 21, 2016

      Drugmakers call for collective action on superbugs

      Most of the world’s biggest pharmaceuticals groups have backed a declaration committing the industry to help tackle...

    25. January 12, 2016

      Pressure builds on GSK with US filing for generic Advair

      GlaxoSmithKline has moved a step closer to losing US market exclusivity on its best-selling asthma drug after Mylan...

    26. January 3, 2016

      GSK and AstraZeneca prescribe different treatments

      For GlaxoSmithKline and AstraZeneca — twin pillars of Britain’s pharmaceuticals sector — 2016 promises to be a critical...

    27. January 3, 2016

      GSK chief fights back to regain investor faith

      GlaxoSmithKline’s embattled chief executive is preparing to launch a big push to reset investor perceptions of the...

    28. December 6, 2015

      China healthcare: Missing a beat

      Not long after taking the helm of GlaxoSmithKline in 2008, Sir Andrew Witty visited Shanghai to deliver a message along...

    29. FT Alphaville

      November 26, 2015

      FT Opening Quote - GSK expects China growth

      GSK expects to see a return to growth in China, amid Mao quotations and Autumn statements. FT Opening Quote, with...

    30. November 15, 2015

      AstraZeneca urges antibiotics investment shake-up

      AstraZeneca has urged the government to develop a new model for incentivising investment in antibiotics and warned of...

    31. November 3, 2015

      GSK unveils new drugs to boost growth

      GlaxoSmithKline has revealed details of dozens of new drugs that it says will help drive recovery in the UK...

    32. November 2, 2015

      Pfizer spurned by GSK before Allergan talks

      Pfizer approached GlaxoSmithKline about a possible takeover in recent weeks but was rebuffed before confirming its...

    33. October 28, 2015

      HIV drugs and vaccines help GSK beat forecasts

      GlaxoSmithKline has urged shareholders to keep faith with its turnround efforts as the struggling UK drugmaker said it...

    34. October 23, 2015

      GSK chief signals decline of US drug price inflation

      Pharmaceuticals companies will no longer be able to rely on ever increasing prices in the US as the world’s biggest...

    35. September 24, 2015

      Pharmaceuticals: Value over volume

      It was probably the most expensive tweet in history. A 21-word missive from Hillary Clinton on Monday wiped more than...

    36. September 9, 2015

      Respiratory drug trial failure deals blow to GSK revival plan

      GlaxoSmithKline has suffered a blow in its efforts to rebuild its struggling respiratory drugs portfolio after a...

    37. July 27, 2015

      David Cameron replaces his entire business advisory board

      David Cameron has overhauled his entire business advisory board as the prime minister brings in a crop of chief...

    38. July 2, 2015

      GSK’s Viiv arm agrees China tie-up to produce HIV drugs

      GlaxoSmithKline has signed a deal to manufacture cut-price HIV drugs in China in a sign that the UK group is rebuilding...

    Search for Andrew Witty and

    RELATED VIDEOS

    Videos from FT.com that closely match this topic

    1. Sir Andrew Witty’s strategy for returning GlaxoSmithKline to ...
      May 11, 2015

      Sir Andrew Witty’s strategy for returning GlaxoSmithKli...